David R.W. Jayne - May 18, 2022 Form 4/A - Amendment Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Director
Signature: /s/ David R.W. Jayne, M.D.
Stock symbol: AUPH
Transactions as of: May 18, 2022
Transactions value $: $36,200
Form type: 4/A - Amendment
Date filed: 7/11/2022, 06:16 AM
Date Of Original Report: May 20, 2022
Previous filing: Jun 16, 2021
Next filing: May 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Options Exercise	$36.2K	+10K	+33.33%	$3.62	40K	May 18, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUPH	Stock Option (right to buy)	Options Exercise	$0	-10K	-100%	$0.00^*	0	May 18, 2022	Common Stock	10K	$3.62	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
F2	The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date.

Remarks:

This amendment is filed to correct the inadvertent omission of the option exercise transaction from the Reporting Person's Form 4 filed on May 20, 2022.